|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Massarweh NN and El-Serag HB: Epidemiology
of hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Cancer Control. 24:10732748177292452017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Center MM and Jemal A: International
trends in liver cancer incidence rates. Cancer Epidemiol Biomarkers
Prev. 20:2362–2368. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yu J, Shen J, Sun TT, Zhang X and Wong N:
Obesity, insulin resistance, NASH and hepatocellular carcinoma.
Semin Cancer Biol. 23:483–491. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Augustine MM and Fong Y: Epidemiology and
risk factors of biliary tract and primary liver tumors. Surg Oncol
Clin N Am. 23:177–188. 2014. View Article : Google Scholar
|
|
6
|
Lawrence MS, Stojanov P, Polak P, Kryukov
GV, Cibulskis K, Sivachenko A, Carter SL, Stewart C, Mermel CH,
Roberts SA, et al: Mutational heterogeneity in cancer and the
search for new cancer-associated genes. Nature. 499:214–218. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dees ND, Zhang Q, Kandoth C, Wendl MC,
Schierding W, Koboldt DC, Mooney TB, Callaway MB, Dooling D, Mardis
ER, et al: MuSiC: Identifying mutational significance in cancer
genomes. Genome Res. 22:1589–1598. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Totoki Y, Tatsuno K, Covington KR, Ueda H,
Creighton CJ, Kato M, Tsuji S, Donehower LA, Slagle BL, Nakamura H,
et al: Trans-ancestry mutational landscape of hepatocellular
carcinoma genomes. Nat Genet. 46:1267–1273. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gonzalez-Perez A and Lopez-Bigas N:
Functional impact bias reveals cancer drivers. Nucleic Acids Res.
40:e1692012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sim NL, Kumar P, Hu J, Henikoff S,
Schneider G and Ng PC: SIFT web server: Predicting effects of amino
acid substitutions on proteins. Nucleic Acids Res. 40(Web Server
Issue): W452–W457. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Adzhubei IA, Schmidt S, Peshkin L,
Ramensky VE, Gerasimova A, Bork P, Kondrashov AS and Sunyaev SR: A
method and server for predicting damaging missense mutations. Nat
Methods. 7:248–249. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Reva B, Antipin Y and Sander C: Predicting
the functional impact of protein mutations: Application to cancer
genomics. Nucleic Acids Res. 39:e1182011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Vandin F, Upfal E and Raphael BJ: De novo
discovery of mutated driver pathways in cancer. Genome Res.
22:375–385. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cancer Genome Atlas Research Network, .
Electronic address. simplewheeler@bcm.eduCancer
Genome Atlas Research Network: Comprehensive and integrative
genomic characterization of hepatocellular carcinoma. Cell.
169:1327–1341.e23. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
McLaren W, Pritchard B, Rios D, Chen Y,
Flicek P and Cunningham F: Deriving the consequences of genomic
variants with the ensembl API and SNP effect predictor.
Bioinformatics. 26:2069–2070. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ashburner M, Ball CA, Blake JA, Botstein
D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT,
et al: Gene ontology: Tool for the unification of biology. The Gene
Ontology Consortium. Nat Genet. 25:25–29. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
The Gene Ontology Consortium, . Expansion
of the gene ontology knowledgebase and resources. Nucleic Acids
Res. 45:D331–D338. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kanehisa M, Furumichi M, Tanabe M, Sato Y
and Morishima K: KEGG: New perspectives on genomes, pathways,
diseases and drugs. Nucleic Acids Res. 45:D353–D361. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Szklarczyk D, Morris JH, Cook H, Kuhn M,
Wyder S, Simonovic M, Santos A, Doncheva NT, Roth A, Bork P, et al:
The STRING database in 2017: Quality-controlled protein-protein
association networks, made broadly accessible. Nucleic Acids Res.
45:D362–D368. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gao F, Liang H, Lu H, Wang J, Xia M, Yuan
Z, Yao Y, Wang T, Tan X, Laurence A, et al: Global analysis of DNA
methylation in hepatocellular carcinoma by a liquid hybridization
capture-based bisulfite sequencing approach. Clin Epigenetics.
7:862015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Barrett T, Wilhite SE, Ledoux P,
Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH,
Sherman PM, Holko M, et al: NCBI GEO: Archive for functional
genomics data sets-Update. Nucleic Acids Res. 41(Database Issue):
D991–D995. 2013.PubMed/NCBI
|
|
22
|
Anaya J: OncoLnc: Linking TCGA survival
data to mRNAs, miRNAs and lncRNAs. PeerJ Comput Sci. 2:e672016.
View Article : Google Scholar
|
|
23
|
Kulis M and Esteller M: 2-DNA methylation
and cancerEpigenetics and Cancer, Part A. 70. Herceg Z and Ushijima
TBT-A G: Academic Press; pp. 27–56. 2010, View Article : Google Scholar
|
|
24
|
Sato Y, Yoshizato T, Shiraishi Y, Maekawa
S, Okuno Y, Kamura T, Shimamura T, Sato-Otsubo A, Nagae G, Suzuki
H, et al: Integrated molecular analysis of clear-cell renal cell
carcinoma. Nat Genet. 45:860–867. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang C, Mckeithan TW, Gong Q, Zhang W,
Bouska A, Rosenwald A, Gascoyne RD, Wu X, Wang J, Muhammad Z, et
al: IDH2R172 mutations define a unique subgroup of patients with
angioimmunoblastic T-cell lymphoma. Blood. 126:1741–1752. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Betti M, Aspesi A, Biasi A, Casalone E,
Ferrante D, Ogliara P, Gironi LC, Giorgione R, Farinelli P, Grosso
F, et al: CDKN2A and BAP1 germline mutations predispose to melanoma
and mesothelioma. Cancer Lett. 378:120–130. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nome T, Hoff AM, Bakken AC, Rognum TO,
Nesbakken A and Skotheim RI: High frequency of fusion transcripts
involving TCF7L2 in colorectal cancer: Novel fusion partner and
splice. PLoS One. 9:e912642014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Inamoto S, Itatani Y, Yamamoto T,
Minamiguchi S, Hirai H, Iwamoto M, Hasegawa S, Taketo MM, Sakai Y
and Kawada K: Loss of SMAD4 promotes colorectal cancer progression
by accumulation of myeloid-derived suppressor cells through the
CCL15-CCR1 chemokine axis. Clin Cancer Res. 22:492–501. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mura M, Hopkins TG, Michael T, Abd-Latip
N, Weir J, Aboagye E, Mauri F, Jameson C, Sturge J, Gabra H, et al:
LARP1 post-transcriptionally regulates mTOR and contributes to
cancer progression. Oncogene. 34:5025–5036. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Paik SS, Jang KS, Song YS, Jang SH, Min
KW, Han HX, Na W, Lee KH, Choi D and Jang SJ: Reduced expression of
Apaf-1 in colorectal adenocarcinoma correlates with tumor
progression and aggressive phenotype. Ann Surg Oncol. 14:3453–3459.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Christoph F, Kempkensteffen C, Weikert S,
Köllermann J, Krause H, Miller K, Schostak M and Schrader M:
Methylation of tumour suppressor genes APAF-1 and DAPK-1 and in
vitro effects of demethylating agents in bladder and kidney cancer.
Br J Cancer. 95:1701–1707. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ishizawa J, Kojima K, Hail N Jr, Tabe Y
and Andreeff M: Expression, function, and targeting of the nuclear
exporter chromosome region maintenance 1 (CRM1) protein. Pharmacol
Ther. 153:25–35. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yoshimura M, Ishizawa J, Ruvolo V, Dilip
A, Quintás-Cardama A, McDonnell TJ, Neelapu SS, Kwak LW, Shacham S,
Kauffman M, et al: Induction of p53-mediated transcription and
apoptosis by exportin-1 (XPO1) inhibition in mantle cell lymphoma.
Cancer Sci. 105:795–801. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gao W, Lu C, Chen L and Keohavong P:
Overexpression of CRM1: A characteristic feature in a transformed
phenotype of lung carcinogenesis and a molecular target for lung
cancer adjuvant therapy. J Thorac Oncol. 10:815–825. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhou F, Qiu W, Yao R, Xiang J, Sun X, Liu
S, Lv J and Yue L: CRM1 is a novel independent prognostic factor
for the poor prognosis of gastric carcinomas. Med Oncol.
30:7262013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kojima K, Kornblau SM, Ruvolo V, Dilip A,
Duvvuri S, Davis RE, Zhang M, Wang Z, Coombes KR, Zhang N, et al:
Prognostic impact and targeting of CRM1 in acute myeloid leukemia.
Blood. 121:4166–4174. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Huang WY, Yue L, Qiu WS, Wang LW, Zhou XH
and Sun YJ: Prognostic value of CRM1 in pancreas cancer. Clin
Invest Med. 32:E3152009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Cairns RA, Iqbal J, Lemonnier F, Kucuk C,
de Leval L, Jais JP, Parrens M, Martin A, Xerri L, Brousset P, et
al: IDH2 mutations are frequent in angioimmunoblastic T-cell
lymphoma. Blood. 119:1901–1903. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Koh J, Cho H, Kim H, Kim SI, Yun S, Park
CK, Lee SH, Choi SH and Park SH: IDH2 mutation in gliomas including
novel mutation. Neuropathology. 35:236–244. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Green CL, Evans CM, Zhao L, Hills RK,
Burnett AK, Linch DC and Gale RE: The prognostic significance of
IDH2 mutations in AML depends on the location of the mutation.
Blood. 118:409–412. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Liu WR, Tian MX, Jin L, Yang LX, Ding ZB,
Shen YH, Peng YF, Zhou J, Qiu SJ, Dai Z, et al: High expression of
5-hydroxymethylcytosine and isocitrate dehydrogenase 2 is
associated with favorable prognosis after curative resection of
hepatocellular carcinoma. J Exp Clin Cancer Res. 33:322014.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wang XW, Ciccarino P, Rossetto M,
Boisselier B, Marie Y, Desestret V, Gleize V, Mokhtari K, Sanson M
and Labussière M: IDH mutations: Genotype-phenotype correlation and
prognostic impact. Biomed Res Int. 2014:5402362014.PubMed/NCBI
|
